Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan

• Yusuke Karasawa ,

  Roles Conceptualization, Methodology, Writing – review & editing

  * E-mail: yusuke.karasawa@viatris.com

  Affiliation Medical Affairs, Viatris Pharmaceuticals Japan Inc., Tokyo, Japan

  ⨯
• Isao Kamae,

  Roles Writing – review & editing

  Affiliation Department of Health Policy and Technology Assessment, Graduate School of Public Policy, The University of Tokyo, Tokyo, Japan

  ⨯
• Kazutaka Nozawa,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Medical Affairs, Viatris Pharmaceuticals Japan Inc., Tokyo, Japan

  ⨯
• Shigeki Zeniya,

  Roles Formal analysis

  Affiliation CRECON Medical Assessment Inc., Tokyo, Japan

  ⨯
• Tatsunori Murata,

  Roles Writing – original draft

  Affiliation CRECON Medical Assessment Inc., Tokyo, Japan

  ⨯
• Satoshi Soen,

  Roles Writing – review & editing

  Affiliation Soen Orthopaedics, Osteoporosis and Rheumatology Clinic, Kobe, Japan

  ⨯
• Choitsu Sakamoto

  Roles Writing – review & editing

  Affiliation Department of Gastroenterology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan

  ⨯